American Medical Association Reconsiders Marijuana

USE OF CANNABIS FOR MEDICINAL PURPOSES

The Council on Science and Public Health recommends that the following statement be adopted in lieu of Resolutions 910 (I-08), 921 (I-08), and 229 (A-09) and the remainder of the report be filed.

Our American Medical Association (AMA) urges that marijuana’s status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines. This should not be viewed as an endorsement of state-based medical cannabis programs, the legalization of marijuana, or that scientific evidence on the therapeutic use of cannabis meets the current standards for a prescription drug product. (New HOD Policy)

http://www.ama-assn.org/assets/meeting/mm/i-09-statements-recommendations.pdf
So it it might have come as a surprise on Tuesday when the AMA announced that, after 72 years, it was reversing its pot policy—and urged the federal government to do the same. Precipitated by a similar decision by the group’s Medical Student Section, the AMA resolved that “that marijuana’s status as a federal Schedule 1 controlled substance be reviewed,” with the goal of facilitating clinical research, and presented a new medical report, conducted by the AMA Council on Science and Public Health, laying out the drug’s various medical benefits.

Full story and video at: http://www.newsweek.com/blogs/the-human-condition/2009/11/13/the-american-medical-association-reconsiders-marijuana-will-the-justice-department-follow.html

 

Share this page